Thomas Gebhardt

University of Melbourne — Australia

Immunology and Microbiology · Life Sciences

43h-index11.4kcitations156works10.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(58), Immunotherapy and Immune Responses(57), Immune Cell Function and Interaction(57), Cancer Immunotherapy and Biomarkers(27), CAR-T cell therapy research(27)

Publications156 total

Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors
Nature Immunology·2025· 4 citedOpen Access
Guidelines for T cell nomenclature
Nature reviews. Immunology·2025· 11 citedOpen Access
Microbiota-derived butyrate promotes a FOXO1-induced stemness program and preserves CD8+ T cell immunity against melanoma
Immunity·2025· 6 cited
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity
Nature Immunology·2025· 18 citedOpen Access
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumours
2025· 2 citedOpen Access
CD4+ T cells in Antitumour Immunity
Elsevier eBooks·2025
Recirculating and Resident Memory CD8+ T Cells
Elsevier eBooks·2025
Exploiting Unique Features of Microneedles to Modulate Immunity
Advanced Materials·2024· 2 citedOpen Access
GPR41 and GPR43 regulate CD8+ T cell priming during herpes simplex virus type 1 infection
Frontiers in Immunology·2024· 6 citedOpen Access
CD4 <sup>+</sup> T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
Science Immunology·2024· 59 cited
Stem-like exhausted and memory CD8+ T cells in cancer
Nature reviews. Cancer·2023· 168 cited
Exploiting Unique Features of Microneedles to Modulate Immunity
Advanced Materials·2023· 44 citedOpen Access
The multifaceted roles of CD4+ T cells and MHC class II in cancer surveillance
Current Opinion in Immunology·2023· 17 cited
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity
Nature Immunology·2023· 34 citedOpen Access
Figure S1 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
Figure S3 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
Figure S2 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
Figure S2 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
Figure S3 from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
Data from CD103&lt;sup&gt;+&lt;/sup&gt; Tumor-Resident CD8&lt;sup&gt;+&lt;/sup&gt; T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Sammy Bedoui(18), William R. Heath(15), Laura K. Mackay(12), Scott N. Mueller(9), Francis R. Carbone(9), Federico Carbone(7), Paul G. Whitney(6), Umaimainthan Palendira(6), Nicholas Collins(5), Jarem Edwards(5), Simone L. Park(5), David C. Tscharke(4), Ali Zaid(4), Asolina Braun(4), Katharina Hochheiser(4), Andrëw G. Brööks(4), Jason Waithman(4), Michael P. Manns(4), Stephan C. Bischoff(4), Stephan von Hörsten(4)